M/S AUTHORGEN TECHNOLOGIES PVT.LTD,MOHALI vs. PR.CIT-1, CHANDIGARH

Bench: SHRI. AAKASH DEEP JAIN (Vice President), SHRI. VIKRAM SINGH YADAV (Accountant Member)

68 of the Income Tax Act, 1961 even though the appellant being resident, has provided complete explanation about the nature and source of sum so credited.” 4. At the outset, it is noted that there is delay in filing the appeal by the Assessee against the order passed by the Ld. Pr. CIT under section 263 dt. 23/03/2021

AUTHORGEN TECHNOLOGIES PVT. LTD.,MOHALI vs. ITO, WARD 6(1), CHANDIGARH

Bench: SHRI. AAKASH DEEP JAIN (Vice President), SHRI. VIKRAM SINGH YADAV (Accountant Member)

68 of the Income Tax Act, 1961 even though the appellant being resident, has provided complete explanation about the nature and source of sum so credited.” 4. At the outset, it is noted that there is delay in filing the appeal by the Assessee against the order passed by the Ld. Pr. CIT under section 263 dt. 23/03/2021

NEERU ARORA,CHANDIGARH vs. CIRCLE-1, INTERNATIONAL TAXATION, CHANDIGARH

In the result, the appeal of the assessee is partly allowed in terms indicated above

Bench: SHRI. LALIET KUMAR (Judicial Member), SHRI. MANOJ KUMAR AGGARWAL (Accountant Member)

144C(2) on 31.03.2023, along with Form No. 35A and various annexures, challenging the year of taxability, the incorrect application of section 50C, and the denial of deduction for the cost of acquisition. 8. The assessee contended that the transfer of the capital asset was completed in A.Y. 2010-11 when possession was handed over and full consideration

JAMYANG KHYENTSE YESHI,KANGRA, HIMACHAL PRADESH vs. ACIT, DCIT, C.R. BUILDING, CHANDIGARH

The appeal of the assessee is partly allowed

Bench: The Ld. Cit(A). The Ld. Cit(A), After Calling For A Remand Report Under Rule 46A, Recorded The Following Findings (Para 5.1 To 5.5 Of The Appellate Order):

68 to 69 B and 69C are different. The Ld. AR had further submitted that in view that there is no repeal and saving clause after insertion of the eligible assessee in section 144C(15), the assessment initially initiated under the old regime cannot be completed in the new regime and for the above-mentioned purposes, he relied upon

M/S JOSAN INDUSTRIES,JALALABAD vs. DCIT, CL-1, INTL. TAXATION, CHANDIGARH

In the result, the appeal is partly allowed as indicated

Bench: Shri A.D. Jain & Shri Vikram Singh Yadavआयकर अपील सं./ Ita Nos. 64 To 66/Chd/2023 "नधा"रण वष" / Assessment Years : 2013-14, 2014-15 & 2015-16 Josan Industries, Vs. The Dcit Circle-1, बनाम Jalalabad, International Taxation, H.O., Guruharshai, Chandigarh Punjab "थायी लेखा सं./Pan No. Aaafj7294F अपीलाथ"/Appellant ""यथ"/Respondent

1. That the Ld. Assessing Officer passing the Draft Order u/s 144C has exceeded the jurisdiction in as much the residential status of assessee firm is "Resident" and not "NRI" as mentioned in the draft order and as such the order passed is illegal, arbitrary and unjustified. 2. That since the Assessing Officer passing the Draft Assessment Order

M/S JOSAN INDUSTRIES,JALALABAD vs. DCIT, CL-1, INTL. TAXATION, CHANDIGARH

In the result, the appeal is partly allowed as indicated

Bench: Shri A.D. Jain & Shri Vikram Singh Yadavआयकर अपील सं./ Ita Nos. 64 To 66/Chd/2023 "नधा"रण वष" / Assessment Years : 2013-14, 2014-15 & 2015-16 Josan Industries, Vs. The Dcit Circle-1, बनाम Jalalabad, International Taxation, H.O., Guruharshai, Chandigarh Punjab "थायी लेखा सं./Pan No. Aaafj7294F अपीलाथ"/Appellant ""यथ"/Respondent

1. That the Ld. Assessing Officer passing the Draft Order u/s 144C has exceeded the jurisdiction in as much the residential status of assessee firm is "Resident" and not "NRI" as mentioned in the draft order and as such the order passed is illegal, arbitrary and unjustified. 2. That since the Assessing Officer passing the Draft Assessment Order

M/S JOSAN INDUSTRIES,JALALABAD vs. DCIT, CL-1, INTL. TAXATION, CHANDIGARH

In the result, the appeal is partly allowed as indicated

Bench: Shri A.D. Jain & Shri Vikram Singh Yadavआयकर अपील सं./ Ita Nos. 64 To 66/Chd/2023 "नधा"रण वष" / Assessment Years : 2013-14, 2014-15 & 2015-16 Josan Industries, Vs. The Dcit Circle-1, बनाम Jalalabad, International Taxation, H.O., Guruharshai, Chandigarh Punjab "थायी लेखा सं./Pan No. Aaafj7294F अपीलाथ"/Appellant ""यथ"/Respondent

1. That the Ld. Assessing Officer passing the Draft Order u/s 144C has exceeded the jurisdiction in as much the residential status of assessee firm is "Resident" and not "NRI" as mentioned in the draft order and as such the order passed is illegal, arbitrary and unjustified. 2. That since the Assessing Officer passing the Draft Assessment Order

ACIT, CHANDIGARH vs. M/S GLAXO SMITHKLINE ASIA PVT. LTD., GURGAON

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

1 Strides Pharma Science Ltd. -24.7% 2 Kilitch Drugs (India) Ltd. - 11.2% 3 Celebrity Biopharma Ltd. -10.0% 4 Colinz Laboratories Ltd. -0.3% 5 Syschcm (India) Ltd. -0.2% 6 Ozone Pharmaceuticals Ltd. 0.3% 7 Laboratories Ltd. 2.1% 8 Elysium Pharmaceuticals Ltd. 2.3% 9 Resonance Specialties Ltd. 2.5% ITA Nos.219 to 222,225 to 227,242, 228, 344/Chd/2017 ITA No.1495/Chd/2019 A.Ys

ACIT, CHANDIGARH vs. M/S GLAXO SMITHKLINE ASIA PVT. LTD., GURGAON

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

1 Strides Pharma Science Ltd. -24.7% 2 Kilitch Drugs (India) Ltd. - 11.2% 3 Celebrity Biopharma Ltd. -10.0% 4 Colinz Laboratories Ltd. -0.3% 5 Syschcm (India) Ltd. -0.2% 6 Ozone Pharmaceuticals Ltd. 0.3% 7 Laboratories Ltd. 2.1% 8 Elysium Pharmaceuticals Ltd. 2.3% 9 Resonance Specialties Ltd. 2.5% ITA Nos.219 to 222,225 to 227,242, 228, 344/Chd/2017 ITA No.1495/Chd/2019 A.Ys

GLAXOSMITHKLINE ASIA PVT. LTD.,GURGAON vs. ACIT, CHANDIGARH

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

1 Strides Pharma Science Ltd. -24.7% 2 Kilitch Drugs (India) Ltd. - 11.2% 3 Celebrity Biopharma Ltd. -10.0% 4 Colinz Laboratories Ltd. -0.3% 5 Syschcm (India) Ltd. -0.2% 6 Ozone Pharmaceuticals Ltd. 0.3% 7 Laboratories Ltd. 2.1% 8 Elysium Pharmaceuticals Ltd. 2.3% 9 Resonance Specialties Ltd. 2.5% ITA Nos.219 to 222,225 to 227,242, 228, 344/Chd/2017 ITA No.1495/Chd/2019 A.Ys

GLAXOSMITHKLINE ASIA PVT. LTD.,GURGAON vs. ACIT, CHANDIGARH

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

1 Strides Pharma Science Ltd. -24.7% 2 Kilitch Drugs (India) Ltd. - 11.2% 3 Celebrity Biopharma Ltd. -10.0% 4 Colinz Laboratories Ltd. -0.3% 5 Syschcm (India) Ltd. -0.2% 6 Ozone Pharmaceuticals Ltd. 0.3% 7 Laboratories Ltd. 2.1% 8 Elysium Pharmaceuticals Ltd. 2.3% 9 Resonance Specialties Ltd. 2.5% ITA Nos.219 to 222,225 to 227,242, 228, 344/Chd/2017 ITA No.1495/Chd/2019 A.Ys

GLAXOSMITHKLINE ASIA PVT. LTD.,GURGAON vs. DCIT, CHANDIGARH

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

1 Strides Pharma Science Ltd. -24.7% 2 Kilitch Drugs (India) Ltd. - 11.2% 3 Celebrity Biopharma Ltd. -10.0% 4 Colinz Laboratories Ltd. -0.3% 5 Syschcm (India) Ltd. -0.2% 6 Ozone Pharmaceuticals Ltd. 0.3% 7 Laboratories Ltd. 2.1% 8 Elysium Pharmaceuticals Ltd. 2.3% 9 Resonance Specialties Ltd. 2.5% ITA Nos.219 to 222,225 to 227,242, 228, 344/Chd/2017 ITA No.1495/Chd/2019 A.Ys

GLAXOSMITHKLINE ASIA PVT. LTD.,GURGAON vs. DCIT, CHANDIGARH

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

1 Strides Pharma Science Ltd. -24.7% 2 Kilitch Drugs (India) Ltd. - 11.2% 3 Celebrity Biopharma Ltd. -10.0% 4 Colinz Laboratories Ltd. -0.3% 5 Syschcm (India) Ltd. -0.2% 6 Ozone Pharmaceuticals Ltd. 0.3% 7 Laboratories Ltd. 2.1% 8 Elysium Pharmaceuticals Ltd. 2.3% 9 Resonance Specialties Ltd. 2.5% ITA Nos.219 to 222,225 to 227,242, 228, 344/Chd/2017 ITA No.1495/Chd/2019 A.Ys

M/S GLAXOSMITHKLINE ASIA PVT. LTD.,GURGAON vs. ACIT, CHANDIGARH

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

1 Strides Pharma Science Ltd. -24.7% 2 Kilitch Drugs (India) Ltd. - 11.2% 3 Celebrity Biopharma Ltd. -10.0% 4 Colinz Laboratories Ltd. -0.3% 5 Syschcm (India) Ltd. -0.2% 6 Ozone Pharmaceuticals Ltd. 0.3% 7 Laboratories Ltd. 2.1% 8 Elysium Pharmaceuticals Ltd. 2.3% 9 Resonance Specialties Ltd. 2.5% ITA Nos.219 to 222,225 to 227,242, 228, 344/Chd/2017 ITA No.1495/Chd/2019 A.Ys

M/S GLAXO SMITHKLINE ASIA PVT. LTD.,GURGAON vs. ACIT, C-4(1), CHANDIGARH

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

1 Strides Pharma Science Ltd. -24.7% 2 Kilitch Drugs (India) Ltd. - 11.2% 3 Celebrity Biopharma Ltd. -10.0% 4 Colinz Laboratories Ltd. -0.3% 5 Syschcm (India) Ltd. -0.2% 6 Ozone Pharmaceuticals Ltd. 0.3% 7 Laboratories Ltd. 2.1% 8 Elysium Pharmaceuticals Ltd. 2.3% 9 Resonance Specialties Ltd. 2.5% ITA Nos.219 to 222,225 to 227,242, 228, 344/Chd/2017 ITA No.1495/Chd/2019 A.Ys

M/S GLAXO SMITHKLINE ASIA PVT. LTD.,GURGAON vs. ACIT, C-4(1), CHANDIGARH

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

1 Strides Pharma Science Ltd. -24.7% 2 Kilitch Drugs (India) Ltd. - 11.2% 3 Celebrity Biopharma Ltd. -10.0% 4 Colinz Laboratories Ltd. -0.3% 5 Syschcm (India) Ltd. -0.2% 6 Ozone Pharmaceuticals Ltd. 0.3% 7 Laboratories Ltd. 2.1% 8 Elysium Pharmaceuticals Ltd. 2.3% 9 Resonance Specialties Ltd. 2.5% ITA Nos.219 to 222,225 to 227,242, 228, 344/Chd/2017 ITA No.1495/Chd/2019 A.Ys

M/S GLAXO SMITHKLINE ASIA PVT. LTD.,NABHA vs. DCIT, C-4(1), CHANDIGARH

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

1 Strides Pharma Science Ltd. -24.7% 2 Kilitch Drugs (India) Ltd. - 11.2% 3 Celebrity Biopharma Ltd. -10.0% 4 Colinz Laboratories Ltd. -0.3% 5 Syschcm (India) Ltd. -0.2% 6 Ozone Pharmaceuticals Ltd. 0.3% 7 Laboratories Ltd. 2.1% 8 Elysium Pharmaceuticals Ltd. 2.3% 9 Resonance Specialties Ltd. 2.5% ITA Nos.219 to 222,225 to 227,242, 228, 344/Chd/2017 ITA No.1495/Chd/2019 A.Ys

ACIT, CHANDIGARH vs. M/S GLAXO SMITHKLINE ASIA PVT. LTD., GURGAON

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

1 Strides Pharma Science Ltd. -24.7% 2 Kilitch Drugs (India) Ltd. - 11.2% 3 Celebrity Biopharma Ltd. -10.0% 4 Colinz Laboratories Ltd. -0.3% 5 Syschcm (India) Ltd. -0.2% 6 Ozone Pharmaceuticals Ltd. 0.3% 7 Laboratories Ltd. 2.1% 8 Elysium Pharmaceuticals Ltd. 2.3% 9 Resonance Specialties Ltd. 2.5% ITA Nos.219 to 222,225 to 227,242, 228, 344/Chd/2017 ITA No.1495/Chd/2019 A.Ys